<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-VGLOU1P7</identifier><date>2015</date><creator>Hanžel, Jurij</creator><creator>Šabovič, Mišo</creator><relation>documents/doc/V/URN_NBN_SI_doc-VGLOU1P7_001.pdf</relation><relation>documents/doc/V/URN_NBN_SI_doc-VGLOU1P7_001.txt</relation><format format_type="issue">4</format><format format_type="volume">66</format><format format_type="type">article</format><format format_type="extent">str. 313-317</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">282482688</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-VGLOU1P7</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">cardiovascular disease</subject><subject language_type_id="slv">kardiovaskularne bolezni</subject><subject language_type_id="slv">neželeni učinki</subject><subject language_type_id="slv">statini</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Adverse effects of statins</title><title>Neželeni učinki statinov</title></Record>